We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEF icon
13251
ProShares Short Financials
SEF
$12.9M
$13.9K ﹤0.01%
260
-4,358
-94% -$221K
ATYR
13252
CALL
aTyr Pharma
ATYR
$54.8M
$13.9K ﹤0.01%
6,600
+3,700
+128% +$8.11K
SVRA icon
13253
PUT
Savara
SVRA
$1.11B
$13.8K ﹤0.01%
+7,100
New +$16K
EYPT icon
13254
CALL
EyePoint Inc
EYPT
$1.27B
$13.8K ﹤0.01%
4,700
-4,300
-48% -$15.3K
VISL
13255
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$13.8K ﹤0.01%
2,000
-4,750
-70% -$48.3K
VCNX
13256
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$13.8K ﹤0.01%
164
+128
+356% +$14.1K
RGS icon
13257
PUT
Regis Corp
RGS
$69.3M
$13.8K ﹤0.01%
620
-180
-23% -$4.97K
WWR icon
13258
PUT
Westwater Resources
WWR
$72.7M
$13.8K ﹤0.01%
12,400
-14,700
-54% -$15.3K
FMS icon
13259
Fresenius Medical Care
FMS
$12.7B
$13.8K ﹤0.01%
647
-3,957
-86% -$75.8K
RCAT icon
13260
CALL
Red Cat Holdings
RCAT
$1.7B
$13.7K ﹤0.01%
13,200
+5,000
+61% +$5.74K
CYAN
13261
DELISTED
Cyanotech Corp
CYAN
$13.7K ﹤0.01%
+15,319
New +$17.7K
BVH
13262
PUT
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$13.7K ﹤0.01%
500
+200
+67% +$5.95K
XSVM icon
13263
PUT
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$677M
$13.7K ﹤0.01%
300
-900
-75% -$43.2K
DMYY.WS
13264
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
$13.6K ﹤0.01%
43,855
+22,331
+104% +$7.38K
INMB icon
13265
PUT
INmune Bio
INMB
$60.2M
$13.6K ﹤0.01%
2,100
-14,000
-87% -$113K
PHAT icon
13266
PUT
Phathom Pharmaceuticals
PHAT
$775M
$13.6K ﹤0.01%
1,900
-8,600
-82% -$75.5K
REAX icon
13267
Real Brokerage
REAX
$523M
$13.5K ﹤0.01%
+11,010
New +$14.5K
RKT icon
13268
Rocket Companies
RKT
$41.8B
$13.5K ﹤0.01%
1,493
-109,740
-99% -$946K
STTK icon
13269
CALL
Shattuck Labs
STTK
$745M
$13.5K ﹤0.01%
4,600
+4,400
+2,200% +$15.6K
KRNLW
13270
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$13.5K ﹤0.01%
112,691
+102
+0.1% +$10
INVA icon
13271
PUT
Innoviva
INVA
$1.53B
$13.5K ﹤0.01%
1,200
-3,800
-76% -$46.1K
RFIL icon
13272
CALL
RF Industries
RFIL
$148M
$13.5K ﹤0.01%
+3,100
New +$15.5K
WHG icon
13273
CALL
Westwood Holdings Group
WHG
$186M
$13.5K ﹤0.01%
+1,200
New +$14.8K
WHG icon
13274
PUT
Westwood Holdings Group
WHG
$186M
$13.5K ﹤0.01%
+1,200
New +$14.8K
AUTL
13275
PUT
Autolus Therapeutics
AUTL
$572M
$13.4K ﹤0.01%
7,300
+5,700
+356% +$11.1K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.